Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Tuberous Sclerosis × Everolimus × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Genitourinary 1 Gastrointestinal 1 Endocrine 1 CNS 1

Conditions

Glioblastoma 12 Brain Neoplasms 12 Glioma 9 Meningioma 7 Central Nervous System Neoplasms 7 Astrocytoma 7 Gliosarcoma 6 Diffuse Intrinsic Pontine Glioma 5 Recurrence 4 Neurofibromatosis 2 4 Neuroma, Acoustic 3 Rhabdomyosarcoma 2 Pheochromocytoma 2 Paraganglioma 2 Oligodendroglioma 2 Neurofibromatosis 1 2 Neoplasms 2 von Hippel-Lindau Disease 1 Zollinger-Ellison Syndrome 1 Vestibulocochlear Nerve Diseases 1 Tuberous Sclerosis 1 Somatostatinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Peripheral Nervous System Diseases 1 Paraganglioma, Extra-Adrenal 1 Otorhinolaryngologic Diseases 1 Neurofibroma, Plexiform 1 Neurofibroma 1

Interventions

Sirolimus 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00789828 2016-02-03

EXIST-1

Novartis

Phase 3 Completed

117 enrolled 15 charts

Astrocytoma, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡